Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools
Roche Holding ROP -1.01%decrease; red down pointing triangle said it agreed to buy PathAI for up to $1.05…
Exclusive | Anthropic Adds Novartis CEO to Board
Anthropic has appointed Vas Narasimhan, chief executive of Swiss pharmaceutical company Novartis NOVN 0.56%increase; green up pointing triangle,…
Zurich Retail Protection Launches Private Client Service –
Sometimes the old school personal touch is the best way, here’s the word from Zurich Retail; Zurich Retail…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN 1.69%increase; green up pointing triangle said it agreed to buy biotech company Excellergy for up to…
UK-Swiss trade deal held up over pharma row – POLITICO
The Swiss are “very angry, understandably, and [the pharmaceutical] industry are angry, because the U.K. has turned around…
UBS Wins U.S. National Charter: Broadening Services for Wealth Management Clients
UBS is set to transform its U.S. entity, UBS Bank USA, into a nationally chartered bank following approval…
20 Years of Expert Wealth Management
Can you share some standout achievements or milestones from the past decade? “A couple of years ago, I…